PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

March of Dimes wants Bendectin back



The morning sickness drug was driven from the market in 1983 by a wave of lawsuits even though health authorities and most juries agreed then and now that it does not cause birth defects; it has been available in Canada all along under the name Diclectin. Bright Line notices that the March of Dimes, which specializes in birth defects prevention, wants the drug back. See Overlawyered, Jul. 21, 1999 and Sept. 27-28, 2000.

 

 


Rafael Mangual
Project Manager,
Legal Policy
rmangual@manhattan-institute.org

Katherine Lazarski
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.